Literature DB >> 17940830

Clinical factors contributing to rapid reoperation for Crohn's disease patients undergoing resection and/or strictureplasty.

David G Binion1, Kenneth R Theriot, Sushrut Shidham, Sarah Lundeen, Ossama Hatoum, Hyun J Lim, Mary F Otterson.   

Abstract

Although surgically induced remission of Crohn's disease following segmental resection/strictureplasty is effective and durable, a subpopulation of patients will require rapid reoperation. We reviewed our inflammatory bowel disease center's database to identify patients who underwent multiple laparotomies. A retrospective analysis of consecutive Crohn's disease patients (1998-2004) was performed, and patients requiring repeat laparotomy were identified. Rapid reoperation was defined as repeat intestinal surgery within 2 years. Demographic data and medical treatment were recorded. Clinical factors contributing to rapid reoperation were defined as (1) symptomatic adhesion, (2) residual strictures/technical error, (3) lack of effective medical therapy, and (4) severe disease despite medical treatment. Of 432 patients, 65 required two or more abdominal explorations, with 32 patients requiring rapid reoperation (50 surgeries). Residual strictures and technical error accounted for 20% of procedures; ineffective medical therapy was identified in 64%, whereas severe disease despite medical therapy was a contributing factor in 14%. Adhesions were found in a single patient. Kaplan-Meier analysis confirmed that rapid reoperation patients had significant and consistently shorter intervals between surgical procedures (i.e., interval between procedures 1 and 2 and 2 and 3). Residual strictures manifest during postop year 1, whereas recurrence of severe disease was the dominant contributing factor during year 2. Our data suggest that operative strategies emphasizing occult stricture detection and adequate medical therapy in Crohn's disease patients may improve outcome and decrease the need for rapid re-exploration.

Entities:  

Mesh:

Year:  2007        PMID: 17940830     DOI: 10.1007/s11605-007-0298-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  33 in total

1.  Strictureplasty for large bowel stenosis in Crohn's disease: quality of life after surgical therapy.

Authors:  D C Broering; C F Eisenberger; A Koch; C Bloechle; W T Knoefel; M Dürig; A Raedler; J R Izbicki
Journal:  Int J Colorectal Dis       Date:  2001-04       Impact factor: 2.571

2.  A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators.

Authors:  B G Feagan; R N Fedorak; E J Irvine; G Wild; L Sutherland; A H Steinhart; G R Greenberg; J Koval; C J Wong; M Hopkins; S B Hanauer; J W McDonald
Journal:  N Engl J Med       Date:  2000-06-01       Impact factor: 91.245

Review 3.  The long-term results of resection and multiple resections in Crohn's disease.

Authors:  A S Krupnick; J B Morris
Journal:  Semin Gastrointest Dis       Date:  2000-01

4.  Patterns of postoperative recurrence in fistulizing and stenotic Crohn's disease. a retrospective cohort study of 71 patients.

Authors:  D B Sachar; K Subramani; K Mauer; S Rivera-MacMurray; P Turtel; C A Bodian; A J Greenstein
Journal:  J Clin Gastroenterol       Date:  1996-03       Impact factor: 3.062

5.  National Cooperative Crohn's Disease Study: factors determining recurrence of Crohn's disease after surgery.

Authors:  H S Mekhjian; D M Switz; H D Watts; J J Deren; R M Katon; F M Beman
Journal:  Gastroenterology       Date:  1979-10       Impact factor: 22.682

6.  Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

Authors:  Stephen B Hanauer; Brian G Feagan; Gary R Lichtenstein; Lloyd F Mayer; S Schreiber; Jean Frederic Colombel; Daniel Rachmilewitz; Douglas C Wolf; Allan Olson; Weihang Bao; Paul Rutgeerts
Journal:  Lancet       Date:  2002-05-04       Impact factor: 79.321

7.  Leflunomide treatment of Crohn's disease patients intolerant to standard immunomodulator therapy.

Authors:  Devang N Prajapati; Joshua F Knox; Jeanne Emmons; Kia Saeian; Mary E Csuka; David G Binion
Journal:  J Clin Gastroenterol       Date:  2003-08       Impact factor: 3.062

8.  Multivariate analysis suggests improved perioperative outcome in Crohn's disease patients receiving immunomodulator therapy after segmental resection and/or strictureplasty.

Authors:  Grace S Tay; David G Binion; Daniel Eastwood; Mary F Otterson
Journal:  Surgery       Date:  2003-10       Impact factor: 3.982

9.  Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial.

Authors:  Stephen B Hanauer; Burton I Korelitz; Paul Rutgeerts; Mark A Peppercorn; Ronald A Thisted; Russell D Cohen; Daniel H Present
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

10.  Risk factors for early postoperative recurrence of Crohn's disease.

Authors:  E Lautenbach; J A Berlin; G R Lichtenstein
Journal:  Gastroenterology       Date:  1998-08       Impact factor: 22.682

View more
  6 in total

Review 1.  A comprehensive review of strictureplasty techniques in Crohn's disease: types, indications, comparisons, and safety.

Authors:  Ronald Ambe; Lorna Campbell; Burt Cagir
Journal:  J Gastrointest Surg       Date:  2011-09-10       Impact factor: 3.452

2.  Impact of postoperative infliximab maintenance therapy on preventing the surgical recurrence of Crohn's disease: a single-center paired case-control study.

Authors:  Toshimitsu Araki; Keiichi Uchida; Yoshiki Okita; Hiroyuki Fujikawa; Mikihiro Inoue; Masaki Ohi; Koji Tanaka; Yasuhiro Inoue; Yasuhiko Mohri; Masato Kusunoki
Journal:  Surg Today       Date:  2013-03-06       Impact factor: 2.549

3.  Factors associated with operative recurrence early after resection for Crohn's disease.

Authors:  Wisam Khoury; Scott A Strong; Victor W Fazio; Ravi P Kiran
Journal:  J Gastrointest Surg       Date:  2011-05-28       Impact factor: 3.452

4.  Strictureplasty for Treatment of Crohn's Disease: an ACS-NSQIP Database Analysis.

Authors:  Cristina B Geltzeiler; J Isaac Young; Brian S Diggs; Kian Keyashian; Karen Deveney; Kim C Lu; V Liana Tsikitis; Daniel O Herzig
Journal:  J Gastrointest Surg       Date:  2015-01-24       Impact factor: 3.452

5.  Role of MutS homolog 2 (MSH2) in intestinal myofibroblast proliferation during Crohn's disease stricture formation.

Authors:  Martin Floer; David G Binion; Victoria M Nelson; Sharon Manley; Michael Wellner; Saba Sadeghi; Behnaz Behmaram; Chloe Sewell; Mary F Otterson; Torsten Kucharzik; Parvaneh Rafiee
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-07-17       Impact factor: 4.052

6.  Risk factors for repeat abdominal surgery in patients with Crohn's disease.

Authors:  Young Jin Kim
Journal:  J Korean Soc Coloproctol       Date:  2012-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.